The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment
Open accessAbstract
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease primarily affecting apocrine gland-rich areas of the body and presenting with painful nodules, abscesses, sinus tracts, and scarring. HS is a multifactorial disease in which genetic and environmental factors play a key role. The primary defect in HS pathophysiology involves follicular occlusion of the folliculopilosebaceous unit, followed by follicular rupture, and immune responses (perifollicular lympho-histiocytic inflammation), finally leading to the development of clinical HS lesions. HS has a destructive impact on the patient's quality of life, being a very challenging disease. Available treatments are limited, mostly off-label and with high variability in the reported efficacy. Fortunately, a monoclonal antibody against tumor necrosis factor alpha has been recently approved for treatment of moderate to severe HS, offering patients a promising new option. This review focuses on the main features of HS, including epidemiology, clinical aspects, pathogenesis, severity classifications, comorbidities, and currently available treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Zouboulis, C. C., Desai, N., Emtestam, L., Hunger, R. E., Ioannides, D., Juhász, I., Lapins, J., Matusiak, L., Prens, E. P., Revuz, J., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12966 · Cited by 1,093
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation
Rangarajan, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3427 · Cited by 866
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Kimball, A. B., Okun, M. M., Williams, D. A., Gottlieb, A. B., Papp, K. A., Zouboulis, C. C., Armstrong, A. W., Kerdel, F., Gold, M. H., Forman, S. B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504370 · Cited by 807
Hidradenitis suppurativa: A comprehensive review
Alikhan, A., Lynch, P. J., & Eisen, D. B. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.11.911 · Cited by 705
Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells
Re, F., & Strominger, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105927200 · Cited by 691
Revuz, J. E., Canoui-Poitrine, F., Wolkenstein, P., Viallette, C., Gabison, G., Pouget, F., Poli, F., Faye, O., Roujeau, J. C., Bonnelye, G., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.06.020 · Cited by 627
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
Sartorius, K., Emtestam, L., Jemec, G. B. E., & Lapins, J. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09198.x · Cited by 525
The prevalence of hidradenitis suppurativa and its potential precursor lesions
Jemec, G. B. E., Heidenheim, M., & Nielsen, N. H. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90321-7 · Cited by 508
γ-Secretase Gene Mutations in Familial Acne Inversa
Wang, B., Yang, W., Wen, W., Sun, J., Su, B., Liu, B., Ma, D., Lv, D., Wen, Y., Qu, T., et al. (2010) · Science · doi:10.1126/science.1196284 · Cited by 451
Kimball, A. B., Kerdel, F., Adams, D., Mrowietz, U., Gelfand, J. M., Gniadecki, R., Prens, E. P., Schlessinger, J., Zouboulis, C. C., van der Zee, H. H., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-12-201212180-00004 · Cited by 428
Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
Schlapbach, C., Hänni, T., Yawalkar, N., & Hunger, R. E. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.07.010 · Cited by 425
Grant, A., Gonzalez, T., Montgomery, M. O., Cardenas, V., & Kerdel, F. A. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.06.050 · Cited by 419
Vazquez, B. G., Alikhan, A., Weaver, A. L., Wetter, D. A., & Davis, M. D. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.255 · Cited by 411
Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa
Jemec, G. B. E., & Wendelboe, P. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70272-5 · Cited by 338
Revuz, J. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03356.x · Cited by 336
Pan, Y., Lin, M.-H., Tian, X., Cheng, H.-T., Gridley, T., Shen, J., & Kopan, R. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.09.014 · Cited by 325
Shlyankevich, J., Chen, A. J., Kim, G. E., & Kimball, A. B. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.09.012 · Cited by 316
Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands
C.-W.YU, C., & COOK, M. G. (1990) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1990.tb06264.x · Cited by 302
Hidradenitis suppurativa: pathogenesis and management
Slade, D. E. M., Powell, B. W., & Mortimer, P. S. (2003) · British Journal of Plastic Surgery · doi:10.1016/s0007-1226(03)00177-2 · Cited by 290
Depression in patients with hidradenitis suppurativa
Onderdijk, A. J., van der Zee, H. H., Esmann, S., Lophaven, S., Dufour, D. N., Jemec, G. B. E., & Boer, J. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04468.x · Cited by 271
Topical Treatment of Hidradenitis Suppurativa with Clindamycin
Clemmensen, O. J. (1983) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1983.tb02150.x · Cited by 270
Gener, G., Canoui-Poitrine, F., Revuz, J. E., Faye, O., Poli, F., Gabison, G., Pouget, F., Viallette, C., Wolkenstein, P., & Bastuji-Garin, S. (2009) · Dermatology · doi:10.1159/000228334 · Cited by 265
Egeberg, A., Gislason, G. H., & Hansen, P. R. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.6264 · Cited by 265
Sartorius, K., Lapins, J., Emtestam, L., & Jemec, G. B. E. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05390.x · Cited by 252
Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa
Sabat, R., Chanwangpong, A., Schneider-Burrus, S., Metternich, D., Kokolakis, G., Kurek, A., Philipp, S., Uribe, D., Wolk, K., & Sterry, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031810 · Cited by 251
Histology of hidradenitis suppurativa
Jemec, G. B. E., & Hansen, U. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90277-7 · Cited by 245
Schrader, A. M. R., Deckers, I. E., van der Zee, H. H., Boer, J., & Prens, E. P. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.04.001 · Cited by 243
Pathophysiology of hidradenitis suppurativa: An update
Prens, E., & Deckers, I. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.07.045 · Cited by 239
What causes hidradenitis suppurativa?
Ralf Paus, L., Kurzen, H., Kurokawa, I., Jemec, G. B. E., Emtestam, L., Sellheyer, K., Giamarellos‐Bourboulis, E. J., Nagy, I., Bechara, F. G., Sartorius, K., et al. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00712_1.x · Cited by 230
van der Zee, H. H., Boer, J., Prens, E. P., & Jemec, G. B. E. (2009) · Dermatology · doi:10.1159/000228337 · Cited by 222
Mendonça, C. O., & Griffiths, C. E. M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07155.x · Cited by 219
Association of Metabolic Syndrome and Hidradenitis Suppurativa
Miller, I. M., Ellervik, C., Vinding, G. R., Zarchi, K., Ibler, K. S., Knudsen, K. M., & Jemec, G. B. E. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.1165 · Cited by 215
Cosmatos, I., Matcho, A., Weinstein, R., Montgomery, M. O., & Stang, P. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.07.027 · Cited by 213
Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments
van der Zee, H. H., Laman, J. D., Boer, J., & Prens, E. P. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01552.x · Cited by 205
Laffert, M. V., Helmbold, P., Wohlrab, J., Fiedler, E., Stadie, V., & Marsch, W. C. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00915.x · Cited by 205
Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa
Shavit, E., Dreiher, J., Freud, T., Halevy, S., Vinker, S., & Cohen, A. D. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12567 · Cited by 195
The prevalence of metabolic syndrome in patients with hidradenitis suppurativa
Gold, D. A., Reeder, V. J., Mahan, M. G., & Hamzavi, I. H. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.11.014 · Cited by 193
Blok, J. L., Li, K., Brodmerkel, C., Horvátovich, P., Jonkman, M. F., & Horváth, B. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14338 · Cited by 193
The symptomatology of hidradenitis suppurativa in women
JEMEC, G. B. E. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb03227.x · Cited by 191
Mammucari, C., di Vignano, A. T., Sharov, A. A., Neilson, J., Havrda, M. C., Roop, D. R., Botchkarev, V. A., Crabtree, G. R., & Dotto, G. P. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.016 · Cited by 180
Gupta, A. K. (1990) · Archives of Dermatology · doi:10.1001/archderm.126.3.339 · Cited by 177
Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa
Boer, J., & van Gemert, M. J. P. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70530-x · Cited by 176
Shalom, G., Freud, T., Harman‐Boehm, I., Polishchuk, I., & Cohen, A. D. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13777 · Cited by 176
Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa
Miller, I. M., McAndrew, R. J., & Hamzavi, I. (2016) · Dermatologic Clinics · doi:10.1016/j.det.2015.08.002 · Cited by 174
γ-Secretase Mutations in Hidradenitis Suppurativa: New Insights into Disease Pathogenesis
Pink, A. E., Simpson, M. A., Desai, N., Trembath, R. C., & Barker, J. N. W. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.372 · Cited by 170
Zhang, Q., Wang, C., Liu, Z., Liu, X., Han, C., Cao, X., & Li, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.310375 · Cited by 165
Pink, A. E., Simpson, M. A., Desai, N., Dafou, D., Hills, A., Mortimer, P., Smith, C. H., Trembath, R. C., & Barker, J. N. W. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.162 · Cited by 161
Bacterial Pathogens Associated with Hidradenitis Suppurativa, France
Guet‐Revillet, H., Coignard-Biehler, H., Jaïs, J., Quesne, G., Frapy, E., Poirée, S., Guern, A. L., Flèche‐Matéos, A. L., Hovnanian, A., Consigny, P., et al. (2014) · Emerging infectious diseases · doi:10.3201/eid2012.140064 · Cited by 153
Efficacy of Rifampin-Moxifloxacin-Metronidazole Combination Therapy in Hidradenitis Suppurativa
Join‐Lambert, O., Coignard-Biehler, H., Jaïs, J., Guet‐Revillet, H., Poirée, S., Fraitag, S., Jullien, V., Ribadeau-Dumas, F., Thèze, J., Guern, A. L., et al. (2010) · Dermatology · doi:10.1159/000321716 · Cited by 151
Melnik, B. C., & Plewig, G. (2013) · Experimental Dermatology · doi:10.1111/exd.12098 · Cited by 148
Kamp, S., Fiehn, A. K., Stenderup, K., Rosada, C., Pakkenberg, B., Kemp, K., Dam, T. N., & Jemec, G. B. E. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10224.x · Cited by 145
Hunger, R. E., Surovy, A. M., Hassan, A. S., Braathen, L. R., & Yawalkar, N. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08425.x · Cited by 145
Insulin Resistance and Skin Diseases
Napolitano, M., Megna, M., & Monfrecola, G. (2015) · The Scientific World JOURNAL · doi:10.1155/2015/479354 · Cited by 138
Self-citationvan der Zee, H. H., Laman, J. D., de Ruiter, L., Dik, W. A., & Prens, E. P. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10698.x · Cited by 138
Richette, P., Moltó, A., Viguier, M., Dawidowicz, K., Hayem, G., Nassif, A., Wendling, D., Aubin, F., Lioté, F., & Bachelez, H. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.130977 · Cited by 129
Fardet, L., Dupuy, A., Kérob, D., Levy, A., Allez, M., Bégon, E., Bachelez, H., Morel, P., & Lebbé, C. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.027 · Cited by 128
Altered innate and adaptive immune responses in patients with hidradenitis suppurativa
Giamarellos‐Bourboulis, E. J., Antonopoulou, A., Petropoulou, C., Mouktaroudi, M., Spyridaki, E., Baziaka, F., Πελεκάνου, Α., Giamarellou, H., & Stavrianeas, N. G. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07556.x · Cited by 125
A family study of hidradenitis suppurativa.
Fitzsimmons, J. S., & Guilbert, P. (1985) · Journal of Medical Genetics · doi:10.1136/jmg.22.5.367 · Cited by 124
Dapsone Therapy for Hidradenitis Suppurativa: A Series of 24 Patients
Yazdanyar, S., Boer, J., Ingvarsson, G., Szepietowski, J. C., & Jemec, G. B. E. (2011) · Dermatology · doi:10.1159/000329023 · Cited by 121
Emelianov, V. U., Bechara, F. G., Gläser, R., Langan, E. A., Taungjaruwinai, W. M., Schröder, J. ‐., Meyer, K. C., & Paus, R. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10765.x · Cited by 117
Join‐Lambert, O., Coignard-Biehler, H., Jaïs, J., Delage, M., Guet‐Revillet, H., Poirée, S., Duchatelet, S., Jullien, V., Hovnanian, A., Lortholary, O., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv361 · Cited by 114
Soria, A., Canouï‐Poitrine, F., Wolkenstein, P., et al. (2008) · Dermatology · doi:10.1159/000182261 · Cited by 113
Deckers, I. E., Benhadou, F., Koldijk, M. J., del Mármol, V., Horváth, B., Boer, J., van der Zee, H. H., & Prens, E. P. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.08.031 · Cited by 112
Margesson, L. J., & Danby, F. W. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.07.012 · Cited by 107
Hidradenitis Suppurativa and Concomitant Pyoderma Gangrenosum
Hsiao, J. L., Antaya, R. J., Berger, T. G., Maurer, T. A., Shinkai, K., & Leslie, K. S. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.328 · Cited by 106
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa
Mekkes, J. R., & Bos, J. D. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08332.x · Cited by 105
Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-alpha Inhibitors
Haslund, P., Lee, R., & Jemec, G. B. E. (2009) · Acta Dermato Venereologica · doi:10.2340/00015555-0747 · Cited by 102
Bacteriology of Hidradenitis Suppurativa – Which Antibiotics are the Treatment of Choice?
Matusiak, Ł., Bieniek, A., & Szepietowski, J. C. (2014) · Acta Dermato Venereologica · doi:10.2340/00015555-1841 · Cited by 95
Considering hidradenitis suppurativa as a bacterial biofilm disease
Kathju, S., Lasko, L., & Stoodley, P. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00946.x · Cited by 92
Long-term Successful Adalimumab Therapy in Severe Hidradenitis Suppurativa
Blanco, R., Martínez-Taboada, V. M., Villa, I., Gonzaléz‐Vela, M. C., Fernández‐Llaca, H., Agudo, M., & González-López, M. A. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.49 · Cited by 90
Hidradenitis suppurativa treated with dapsone: A case series of five patients
Kaur, M. R., & Lewis, H. M. (2006) · Journal of Dermatological Treatment · doi:10.1080/09546630600830588 · Cited by 86
Cyclosporin-responsive hidradenitis suppurativa.
Buckley, D. A., & Rogers, S. (1995) · Europe PMC (PubMed Central) · Cited by 85
Acne Inversa: Evaluating Antimicrobial Peptides and Proteins
Bechara, F. G., Sand, M. S., Skrygan, M., Kreuter, A., Altmeyer, P. J., & Gambichler, T. (2012) · Annals of Dermatology · doi:10.5021/ad.2012.24.4.393 · Cited by 82
Bettoli, V., Naldi, L., Cazzaniga, S., Zauli, S., Atzori, L., Borghi, A., Capezzera, R., Caproni, M., Cardinali, C., DeVita, V., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13864 · Cited by 81
Self-citationTreatment of recalcitrant hidradenitis suppurativa with oral ciclosporin.
Rose, R. F., Goodfield, M. J. D., & Clark, S. M. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01983.x · Cited by 81
Infliximab for the treatment of hidradenitis suppurativa
Lebwohl, B., & Sapadin, A. N. (2003) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)01132-0 · Cited by 80
Expression of innate defense antimicrobial peptides in hidradenitis suppurativa
Hofmann, S. C., Saborowski, V., Lange, S., Kern, W. V., Bruckner‐Tuderman, L., & Rieg, S. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.07.020 · Cited by 80
Esmann, S., Dufour, D., & Jemec, G. B. E. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09773.x · Cited by 77
Emerging role of leptin in rheumatoid arthritis
Tian, G., Liang, J.-N., Wang, Z.-Y., & Zhou, D. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12372 · Cited by 75
Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients
Jahns, A. C., Killasli, H., Nosek, D., Lundskog, B., Lenngren, A., Muratova, Z., Emtestam, L., & Alexeyev, O. A. (2014) · Apmis · doi:10.1111/apm.12220 · Cited by 69
Management of Recalcitrant Hidradenitis Suppurativa with Ustekinumab
Sharon, V. R., Garcia, M., Bagheri, S., Goodarzi, H., Yang, C., Ono, Y., & Maverakis, E. M. (2012) · Acta Dermato Venereologica · doi:10.2340/00015555-1229 · Cited by 69
The homogeneity of hidradenitis suppurativa lesions
Jemec, G. B. E., Thomsen, B. M., & HANSEN, U. (1997) · Apmis · doi:10.1111/j.1699-0463.1997.tb00584.x · Cited by 67
Arthritis associated with hidradenitis suppurativa.
Bhalla, R., & Sequeira, W. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.1.64 · Cited by 66
Hidradenitis Suppurativa Complicated by Squamous Cell Carcinoma
Constantinou, C., Widom, K. A., DeSantis, J. G., & Obmann, M. A. (2008) · The American Surgeon · doi:10.1177/000313480807401209 · Cited by 64
Monfrecola, G., Balato, A., Caiazzo, G., Vita, V. D., Caprio, R. D., Donnarumma, M., Lembo, S., & Fabbrocini, G. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13233 · Cited by 64
Self-citationSuccessful treatment of hidradenitis suppurativa with acitretin
Hogan, D. J., & Light, M. J. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)80251-2 · Cited by 64
Brown, T. J., ROSEN, T., & Orengo, I. F. (1998) · Southern Medical Journal · doi:10.1097/00007611-199812000-00003 · Cited by 64
Interobserver variability of clinical scores in hidradenitis suppurativa is low
Sartorius, K., Killasli, H., Heilborn, J. D., Jemec, G. B. E., Lapins, J., & Emtestam, L. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09715.x · Cited by 62
Cosmatos, I. S., Matcho, A., Weinstein, R. B., Montgomery, M. O., & Stang, P. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.06.042 · Cited by 52
Long-term efficacy of infliximab in hidradenitis suppurativa
Paradela, S., Rodríguez-Lojo, R., Fernández‐Torres, R., Bermúdez, M. D. P. A., & Fonseca, E. (2012) · Journal of Dermatological Treatment · doi:10.3109/09546634.2012.683767 · Cited by 51
Infliximab for the Treatment of Hidradenitis Suppurativa
Fernández-Vozmediano, J. M., & Armario-Hita, J. C. (2007) · Dermatology · doi:10.1159/000102032 · Cited by 47
Failure of treatment of familial widespread hidradenitis suppurativa with isotretinoin
Norris, J. F. B., & Cunliffe, W. J. (1986) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1986.tb00512.x · Cited by 47
Hidradenitis suppurativa: are tumour necrosis factor-α blockers the ultimate alternative?
Brunasso, A. M. G., Delfino, C., & Massone, C. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08735.x · Cited by 45
Sebum Excretion in Hidradenitis suppurativa
Jemec, G. B. E., & Gniadecka, M. (2009) · Dermatology · doi:10.1159/000246125 · Cited by 44
Scheinfeld, N. S. (2014) · Dermatology Online Journal · doi:10.5070/d3203021764 · Cited by 41
Cyclosporine treatment of severe Hidradenitis suppurativa – A case series
Anderson, M. D., Zauli, S., Bettoli, V., Boer, J., & Jemec, G. B. E. (2015) · Journal of Dermatological Treatment · doi:10.3109/09546634.2015.1088128 · Cited by 40
Meixner, D., Schneider‐Burrus, S., Krause, M., & Sterry, W. (2007) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2007.06492.x · Cited by 40
Hidradenitis suppurativa managed with adalimumab.
Yamauchi, P. S., & Mau, N. (2009) · PubMed · Cited by 34
Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report.
Scheman, A. J. (2002) · PubMed · Cited by 33
Tan, M. G., Shear, N. H., Walsh, S. R., & Alhusayen, R. O. (2016) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475416659858 · Cited by 27
Pink, A., Simpson, M. A., Desai, N., Smith, C. H., Hills, A. E., Mortimer, P. S., Trembath, R. C., & Barker, J. N. (2012) · Research Portal (King's College London) · Cited by 20
Rashidghamat, E. (2022) · Wiley eBooks · doi:10.1002/9781119755173.ch25 · Cited by 12
Cited by
Alikhan, A., Sayed, C., Alavi, A., Alhusayen, R., Brassard, A., Burkhart, C., Crowell, K., Eisen, D. B., Gottlieb, A. B., Hamzavi, I., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.02.067 · Cited by 400
Nguyen, T. V., Damiani, G., Orenstein, L. A. V., Hamzavi, I., & Jemec, G. B. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16677 · Cited by 391
Hidradenitis Suppurativa: Where We Are and Where We Are Going
Scala, E., Cacciapuoti, S., Garzorz-Stark, N., Megna, M., Marasca, C., Seiringer, P., Volz, T., Eyerich, K., & Fabbrocini, G. (2021) · Cells · doi:10.3390/cells10082094 · Cited by 135
“In this scenario, bacterial colonization is considered a secondary pathogenic factor that can worsen HS [2,4].”
BackgroundInfluentialSelf-citationNew and Emerging Targeted Therapies for Hidradenitis Suppurativa
Markota Čagalj, A., Marinović, B., & Bukvić Mokos, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073753 · Cited by 74
Metadata
- Authors
- Napolitano, M., Megna, M., Timoshchuk, E., Patruno, C., Balato, N., Fabbrocini, G., & Monfrecola, G.
- Venue
- Clinical, Cosmetic and Investigational Dermatology
- Publisher
- Informa UK Limited
- Published
- 2017-04
- Volume
- Volume 10
- Pages
- 105-115
- ISSN
- 1178-7015 (ISSN-L)
- OpenAlex
- W2606470589
- Cited by
- 253
- References
- 102
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.